Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - terazosin hydrochloride - oral tablet - 5mg

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - terazosin hydrochloride - oral tablet - 2mg

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - terazosin hydrochloride - oral tablet - 5mg

Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - terazosin hydrochloride dihydrate 2,375 mg - eq. terazosin 2 mg - tablet - 2 mg - terazosin hydrochloride - terazosin

Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - terazosin hydrochloride dihydrate 5,935 mg - eq. terazosin 5 mg - tablet - 5 mg - terazosin hydrochloride - terazosin

Kanada - anglų - Health Canada

abbott laboratories, limited - terazosin (terazosin hydrochloride); terazosin (terazosin hydrochloride); terazosin (terazosin hydrochloride) - kit - 1mg; 2mg; 5mg - terazosin (terazosin hydrochloride) 1mg; terazosin (terazosin hydrochloride) 2mg; terazosin (terazosin hydrochloride) 5mg - alpha-adrenergic blocking agents

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

physicians total care, inc. - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin 1 mg - terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin capsules. the long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin capsules are also indicated for the treatment of hypertension. terazosin capsules can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin 1 mg - terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin capsules. the long-term effects of terazosin capsules on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin capsules are also indicated for the treatment of hypertension. terazosin capsules can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

quality care products llc - terazosin hydrochloride (unii: d32s14f082) (terazosin - unii:8l5014xet7) - terazosin 5 mg - terazosin hydrochloride is indicated for the treatment of symptomatic benign prostatic hyperplasia (bph). there is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin hydrochloride. the long-term effects of terazosin hydrochloride on the incidence of surgery, acute urinary obstruction or other complications of bph are yet to be determined. terazosin hydrochloride is also indicated for the treatment of hypertension. it can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents. terazosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to terazosin hydrochloride.

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - terazosin hydrochloride - oral tablet - 2mg